Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/11/1991 | EP0445201A1 Nucleoside analogues |
09/11/1991 | EP0445116A1 [(aryl-4-piperazinyl-1)-2 ethoxy]-3 p-cymene, the ortho, meta and para derivatives mono- or disubstituted on the phenyl nucleus of said product, process for preparing said derivatives, and drugs containing said compounds as active ingredients |
09/11/1991 | EP0381747A4 Water soluble branched beta cyclodextrin steroid complex |
09/11/1991 | EP0368953A4 Method and microorganism for the production of faeriefungin |
09/11/1991 | EP0274498B1 Medicaments with delayed release of active ingredient |
09/11/1991 | EP0236342B1 Amino acid derivatives |
09/11/1991 | CN1054419A 6-substituted-hexahydrobenz (cd) indoles and process for preparation therefor |
09/11/1991 | CN1054418A Improvements in and relating to (s) -norfluoxetine |
09/11/1991 | CN1054369A Coated vitamin c preparation for animal feed, production and use thereof |
09/11/1991 | CN1013866B Process for preparation of highly pure acarbose |
09/11/1991 | CN1013865B Quinoline derivatives |
09/11/1991 | CN1013864B Antipsychotic gamma-carbolines |
09/11/1991 | CN1013863B 5-chloro-s-triazole (4.3-alpha)-pyridine-7-carboxylic acids |
09/11/1991 | CN1013860B Ether isonitriles and radiolabeled complexes thereof |
09/10/1991 | WO1991013892A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it |
09/10/1991 | WO1991013890A2 Diastereoisomeric compounds derived from tetrahydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
09/10/1991 | WO1991013870A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
09/10/1991 | WO1991013618A1 Phenyl butyl nitrone compositions for prevention of gastric ulceration |
09/10/1991 | US5047593 Lipoxygenase inhibiting compounds |
09/10/1991 | US5047575 Norbornene carboxylic acids and esters |
09/10/1991 | US5047564 Fluorine-containing vitamin D2 derivatives |
09/10/1991 | US5047554 3-substituted-2-oxindole derivatives |
09/10/1991 | US5047550 Pesticides |
09/10/1991 | US5047534 Xanthine derivatives; hyupotensive agents, cardiotonic agents |
09/10/1991 | US5047525 With cyclodextrin ty |
09/10/1991 | US5047521 Anticarcinogenic agents |
09/10/1991 | US5047435 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections |
09/10/1991 | US5047434 1-(3,5-Dihydroxyphenyl)-2-(Tertiary-Butylamino)-Ethanol |
09/10/1991 | US5047433 N-alkyl derivatives of 2-amino-6,7-dimethoxy tetraline and pharmaceutical compositions having antihypertensive activity containing same |
09/10/1991 | US5047432 Arylcyclobutylmethylamine therapeutic agents |
09/10/1991 | US5047431 Treatment of hormone-dependent mammary tumors; antiestrogens |
09/10/1991 | US5047429 Treatment of oedema |
09/10/1991 | US5047428 Expectorant comprising hydroxyalkylcysteine derivative |
09/10/1991 | US5047427 Administering pyruvic acid or its pharmaceutically acceptable salts to reduce vascular albumin leeakage |
09/10/1991 | US5047425 Amine derivatives having cardiovascular activity |
09/10/1991 | US5047422 Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract |
09/10/1991 | US5047421 Treating trivalent metal overload conditions in humans |
09/10/1991 | US5047419 Photodynamic therapy of glioma or mammary carcinoma using seleno- or telluropyrylium salts |
09/10/1991 | US5047418 Method of stimulating histamine H3 -receptors |
09/10/1991 | US5047416 Triazole compounds and their use as transglutaminase inhibitors |
09/10/1991 | US5047414 2-(aminoalkylthio)methyl-1,4-dihydropyridine, a method for the preparation thereof and pharmaceutical compositions containing them |
09/10/1991 | US5047413 Urogenital disorders |
09/10/1991 | US5047411 Antiulcer Agents, H2-Receptor Antagonists |
09/10/1991 | US5047410 Indolyl derivatives and their use as 5-HT3, receptor antagonists |
09/10/1991 | US5047409 Thiazolidine-4-carboxylic acid salt with 6-piperidino-2,4-diaminopyrimidine-3-oxide |
09/10/1991 | US5047407 Prevention Or Treatment Of Human Immunodeficiency Virus |
09/10/1991 | US5047406 Substituted cyclohexanols as central nervous system agents |
09/10/1991 | US5047405 Antiamnesic use of pteridine derivatives |
09/10/1991 | US5047404 Chemical compounds |
09/10/1991 | US5047403 Administering Phenothiazine |
09/10/1991 | US5047247 Including A Disintegrating Agent, Acid And Antioxidant |
09/10/1991 | US5047246 Direct compression cyclophosphamide tablet |
09/10/1991 | US5047236 Method of treating stroke |
09/10/1991 | US5047235 Pharmaceutical preparations having an antihypertensive and cardioprotective effect |
09/10/1991 | US5047230 Aerosol composition comprising nitroglycerin as active ingredient |
09/10/1991 | US5047229 Treatment of cardiovascular and cerebral toxicity using calcium modulators |
09/10/1991 | CA2077746A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
09/10/1991 | CA2077645A1 Organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it |
09/10/1991 | CA2056433A1 Diastereoisomeric compounds derived from tetra-hydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
09/10/1991 | CA2037955A1 Fluoroelastomers based on vinylidene fluoride, hexafluoropropene and tetrafluoroethylene |
09/10/1991 | CA2037872A1 C-linked pyrazole derivatives |
09/10/1991 | CA2037812A1 Imidazo[1,2-c]quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same |
09/10/1991 | CA2037390A1 Melanogenesis-inhibiting endermic preparation |
09/10/1991 | CA2037153A1 Acetic acid derivatives |
09/10/1991 | CA1288773C Methionine-substituted 1,4-dihydropyridines, process for the preparationand their use |
09/10/1991 | CA1288772C 5,6-dihydro-2-(substituted phenyl)-1,2-4-triazine-3,5 (2h,4h)-diones |
09/10/1991 | CA1288771C Pseudopterosin and synthetic derivatives thereof |
09/10/1991 | CA1288768C Highly pure acarbose |
09/10/1991 | CA1288764C Cephalosporin compounds |
09/10/1991 | CA1288695C Method for increasing bone mass |
09/09/1991 | WO1991013875A1 Sulfonamide derivative and pharmaceutical composition containing the same |
09/09/1991 | CA2037782A1 Process for zein coating of active ingredients |
09/09/1991 | CA2037741A1 Delipidated polysaccharide composition, method for preparing same |
09/09/1991 | CA2037738A1 Active ingredient coating process using a ph-sensitive polymer |
09/09/1991 | CA2037721A1 Substituted-amine compound and a process for the preparation thereof |
09/09/1991 | CA2037665A1 Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors |
09/09/1991 | CA2037654A1 4h-pyrrolo[1,2-a]thieno[3,2-f][1,4]-diazepines, process for the preparation thereof and pharmaceutical compositions containing the same |
09/09/1991 | CA2037638A1 Pyrrolo[1,2-a]thieno[3,2-f]-diazepines[1,4], process for the preparation thereof and pharmaceutical compositions containing the same |
09/08/1991 | WO1991013874A1 Derivatives of glycinamide, their preparation and medicaments containing them |
09/08/1991 | CA2074357A1 Glucinamid derivatives, their preparation and drugs containing them |
09/08/1991 | CA2037610A1 Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application |
09/08/1991 | CA2037590A1 Pyridine derivatives and processes for their synthesis |
09/07/1991 | WO1991013549A1 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections |
09/07/1991 | CA2053849A1 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections |
09/07/1991 | CA2037559A1 5-phenyl-1h-pyrazol-4-propionic acid derivatives their preparation and use |
09/07/1991 | CA2037549A1 Anti-progestomimetic composition used in breeding animals |
09/07/1991 | CA2036750A1 Method and composition for enhancing performance |
09/07/1991 | CA2011656A1 Compounds |
09/06/1991 | WO1991013883A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
09/06/1991 | CA2077543A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
09/06/1991 | CA2037483A1 Aminobenzenesulfonic acid derivative |
09/06/1991 | CA2037467A1 Spirocyclic antipsychotic agents |
09/05/1991 | WO1991013100A1 Cyclodextrin compositions and methods for pharmaceutical and industrial applications |
09/05/1991 | WO1991013092A1 Vasoactive vasotocin derivatives |
09/05/1991 | WO1991013083A1 Steroid sulphatase inhibitors |
09/05/1991 | WO1991013082A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
09/05/1991 | WO1991013076A1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
09/05/1991 | WO1991013060A1 Indole derivatives |
09/05/1991 | WO1991013056A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists |
09/05/1991 | WO1991013055A2 New aryl- and heteroarylethenylene derivatives and process for their preparation |